お知らせ
英文誌「Respiratory Endoscopy」の投稿規定が,2026年8月17日より一部変更となりますのでお知らせ致します.変更点は次の通りです.
日本呼吸器内視鏡学会編集委員会
委員長 猶木 克彦
「Respiratory Endoscopy」Instructions to Authors
Table of Contents
13. Archiving Policy 追加）
13. Advertisement Policy
14. 変更）
3. Manuscript Preparation
3.1 General Formatting
・・・
• Supplemental Files (e.g., videos, if applicable)
• Graphical Abstract
Required Forms 追加）
Authors must prepare the manuscripts according to the following guidelines, and their submission should include a reporting checklist as Checklist. 追加）
• CARE checklist (for case reports) 追加）
• STROBE checklist (for observational studies) 追加）
• CONSORT checklist (for randomized clinical trials) 追加）
• PRISMA checklist (for systematic reviews and meta-analyses) 追加）
3.1.1 Title Page
・・・
• Title of the manuscript (No abbreviations except for gene names or in common use.Include the words "case report" for case reports.)
追加）
3.1.2 Main Document
・・・
The Abstract, regardless of the Article Type, should contain 2-5 key words (Key words must include the words "case report" for case reports). 追加）
・・・
Main Text
・・・
Original Article:
・・・
Number of References: No more than 30
*Limitation section should be included as a subheading within the Discussion section. 追加）
3.2 References
・・・
Three or more consecutive citations should be indicated as a range using a hyphen, e.g. "3-5". If there are more than three authors, name only the first three authors and then use “et al.”
When available, authors are strongly encouraged to include the digital object identifier (DOI) at the end of each reference entry, formatted as “doi: https://doi.org/10.xxxx/xxxxx” (no period after the DOI). 追加）
Examples:
Journal article
1.Guiot BH, Khoo LT, Fessler RG. A minimally invasive technique for decompression of the lumber spine. Spine. 2002;27(4):432-8. doi: https://doi.org/10.1097/00007632-200202150-00021
追加）
8. Peer Review Process
8.1 Revised Manuscript
It is expected that any manuscripts receiving a revision decision will be fully amended according to the comments of both the reviewers and the editors. Authors must also include a detailed point-by-point response letter. Authors should submit the revised manuscript within 3 months from the date of prior
8 weeks 変更）
decision. Revisions must be approved by all authors prior to submission of the revised manuscript.
9. Editorial Policy and Publication Ethics
9.6 Conflicts of Interest and Sources of Funding
・・・
All sources of funding from entities such as government or non-profit organizations, which are relevant to the study, should be acknowledged on the title page under the heading “Sources of Funding.” Funding sources and affiliations that have not contributed to the work should not be listed as listing them would be misleading.
追加）
9.7 Research Ethics
A）Clinical research included in articles that report on human subjects or materials of human origin, must
追加）
comply with the provisions of the Declaration of Helsinki. In addition, the “Materials and Methods” section must include a statement that the research was approved by the IRB of the authors’ affiliated institutions and the approval code issued by the IRB and the name of the institution, which granted the approval. Those researchers who do not have access to an ethics review committees should follow the principles outlined in the Declaration of Helsinki.
For researches exempt from IRB approval, the manuscript must include the reasons for the exemption and a statement confirming that the IRB formally determined the study to be exempt. In addition, authors must clearly state a statement of adherence to the Declaration of Helsinki in the “Materials and Methods” section. 変更）
A) Articles reporting on data from animal testing・・・・
B) 変更
B) Authors of articles reporting on new DNA sequences・・・
C) 変更
C) For any studies involving human subjects・・・
D) 変更
E) Any data or information such as patient names, initials, hospital ・・・
追加）
F) Authors are encouraged to make their research data publicly available to enhance transparency and reproducibility. This includes, but is not limited to, raw or processed data, software, algorithms, protocols, methods, materials specifications, protocols, and analytic code. When data are shared, authors should provide a data availability statement including a DOI or URL linking to the dataset. If the data cannot be shared for legal or ethical reasons, authors should clearly state the reason in the manuscript. The data availability statement will be published with the article. 追加）
In addition, all authors should have the ability to review the data supporting study results. In the case of collaborations between authors from academic and nonacademic institutions, at least one author from the academic institution should have accessed the primary data and be able to participate in the analysis. With sponsored research, authors' access to the supporting data should be expressly provided for in any research agreements. Editors may ask which specific authors had access and participated in the analysis. 追加）
13. Archiving Policy 追加）
Self-archiving Policy 追加）
The Journal allows authors to deposit various versions of their articles in institutional or subject-specific repositories immediately after publication. 追加）
Versions Eligible for Archiving: 追加）
・Preprint: The initial version of the manuscript submitted before peer review and any editorial changes. 追加）
・Author's accepted manuscript: The version of the manuscript that has been peer-reviewed and revised but has not yet undergone final formatting by the Journal. 追加）
・Published article: The peer-reviewed, edited, and formatted version of the article as published by the Journal. 追加）
Authors must provide the bibliographic information (authors, article title, journal title), the name of the copyright holder, the DOI and/or URL to the original publication. 追加）
Dark Archiving / Long-term Preservation Policy 追加）
To ensure long-term preservation and continued access to published content, Respiratory Endoscopy participates in PORTICO. In the event of publisher disruption or journal discontinuation, archived content will remain accessible to the scholarly community. 追加）
13. Advertisement Policy
14変更）
・・・
For inquiries:
Respiratory Endoscopy Editorial Office
Editorial Office Manager: JUDY YU WU, Emi Jimoto 追加）
E-mail: respend@kyorinmail.jp
